{"id":"W4367042670","doi":"10.1200/po.22.00317","title":"Association Between Biomarkers and Clinical Outcomes of Pembrolizumab Monotherapy in Patients With Metastatic Triple-Negative Breast Cancer: KEYNOTE-086 Exploratory Analysis","year":2023,"lang":"en","type":"article","venue":"JCO Precision Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Pembrolizumab; Medicine; Internal medicine; Oncology; Breast cancer; Cohort; Triple-negative breast cancer; Metastatic breast cancer; Tumor-infiltrating lymphocytes; Progression-free survival; Cancer; Immunotherapy; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001209577,0.0004894368,0.0006843944,0.0004145061,0.0002321346,0.0005992645,0.0004995196,0.0004896877,0.001409851],"category_scores_gemma":[0.00150049,0.0002678771,0.0007346824,0.0004510047,0.0001926075,0.0005397556,0.000499095,0.0007041637,0.0002535716],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003559664,"about_ca_system_score_gemma":0.0004225802,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00042156,"about_ca_topic_score_gemma":0.0006705534,"domain_scores_codex":[0.9994373,0.0001791325,0.00004951329,0.0001699228,0.00009869252,0.00006549818],"domain_scores_gemma":[0.9989157,0.0002473514,0.0004406539,0.0001175041,0.00008226185,0.0001966093],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.02822461,0.0007972823,0.9547259,0.0001206454,0.001279218,0.0002035197,0.00007003572,0.0006666264,0.005443669,0.00007696468,0.0006567202,0.007734941],"study_design_scores_gemma":[0.00116559,0.00544603,0.988978,0.00001592609,0.0004867687,0.0003702887,0.00008453739,0.001779226,0.0007971704,0.0000884504,0.0007708012,0.00001725927],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9985024,0.0002402677,0.00009741058,0.00002432876,0.000004289006,0.00003993119,0.0008426172,0.000004579018,0.0002442732],"genre_scores_gemma":[0.9980812,0.0000558023,0.0001684015,0.00003263025,0.00001653741,0.00006640732,0.001415395,0.000002740565,0.0001609606],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001409851,"threshold_uncertainty_score":0.00639689,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03410953094782355,"score_gpt":0.3719527482705692,"score_spread":0.3378432173227457,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}